Decreased bone mineral density in adult patients with Hemophilia

Clinical significance, prevalence and risk factors

Ursa Broum-Glaberman, Michelle Cordoba Kissee, Mary Lou Damiano, Denise Roe, Alison T Stopeck

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Osteoporosis is widely recognized as a major health problem, and considerable resources are spent screening, diagnosing, and treating this disease in postmenopausal women. Adults with hemophilia have unique factors that place them at an increased risk for developing osteoporosis including periods of immobilization after bleeds, impaired joint mobility that may limit weight bearing physical activity, and infection with Hepatitis C virus (HCV) and/orhuman immunodeficiency virus (HIV). Several publications report the prevalence of osteoporosis in adults with hemophilia to be in the range of 25% and 50%. The severity of hem ophilic joint arthropathy appears to be the strongest predictor of significant bone loss in patients with hemophilia. The relative contribution of other risk factors, including HIV and HCV, is less well defined. The clinical significance of decreased bone mineral density as measured by dual energy X-ray absorptiometry (DXA) to fracture risk in men, and in particularyounger men, is also unclear. We recommend screening adult patients with hemophilia with documented fragility fractures, in those with severe joint arthropathy, and in those patients > 50 years of age with additional risk factors such as HIV/HCV infection or low BMI. Adequate vitamin D and calcium intake, weight bearing physical activity, and interventions to maintain joint mobility are recommended for all hemophilia patients. The role of pharmacologic agents, including bisphosphonates, is untested, and they should be reserved for those with documented osteoporosis and fragility fractures or additional risk factors that place them at high risk for developing fragility fractures.

Original languageEnglish (US)
Pages (from-to)27-33
Number of pages7
JournalJournal of Coagulation Disorders
Volume3
Issue number1
StatePublished - Oct 2011

Fingerprint

Hemophilia A
Bone Density
Osteoporosis
Joints
Hepacivirus
Joint Diseases
Weight-Bearing
Viruses
Exercise
Photon Absorptiometry
Diphosphonates
Virus Diseases
Vitamin D
Immobilization
Publications
Calcium
Bone and Bones
Health
Infection

Keywords

  • Bone mineral density
  • Fragility fracture
  • Hemophilia
  • Joint arthropathy
  • Osteopenia
  • Osteoporosis

ASJC Scopus subject areas

  • Hematology

Cite this

Decreased bone mineral density in adult patients with Hemophilia : Clinical significance, prevalence and risk factors. / Broum-Glaberman, Ursa; Kissee, Michelle Cordoba; Damiano, Mary Lou; Roe, Denise; Stopeck, Alison T.

In: Journal of Coagulation Disorders, Vol. 3, No. 1, 10.2011, p. 27-33.

Research output: Contribution to journalArticle

@article{7ccb3e19b88a40698cc14ce635a31c40,
title = "Decreased bone mineral density in adult patients with Hemophilia: Clinical significance, prevalence and risk factors",
abstract = "Osteoporosis is widely recognized as a major health problem, and considerable resources are spent screening, diagnosing, and treating this disease in postmenopausal women. Adults with hemophilia have unique factors that place them at an increased risk for developing osteoporosis including periods of immobilization after bleeds, impaired joint mobility that may limit weight bearing physical activity, and infection with Hepatitis C virus (HCV) and/orhuman immunodeficiency virus (HIV). Several publications report the prevalence of osteoporosis in adults with hemophilia to be in the range of 25{\%} and 50{\%}. The severity of hem ophilic joint arthropathy appears to be the strongest predictor of significant bone loss in patients with hemophilia. The relative contribution of other risk factors, including HIV and HCV, is less well defined. The clinical significance of decreased bone mineral density as measured by dual energy X-ray absorptiometry (DXA) to fracture risk in men, and in particularyounger men, is also unclear. We recommend screening adult patients with hemophilia with documented fragility fractures, in those with severe joint arthropathy, and in those patients > 50 years of age with additional risk factors such as HIV/HCV infection or low BMI. Adequate vitamin D and calcium intake, weight bearing physical activity, and interventions to maintain joint mobility are recommended for all hemophilia patients. The role of pharmacologic agents, including bisphosphonates, is untested, and they should be reserved for those with documented osteoporosis and fragility fractures or additional risk factors that place them at high risk for developing fragility fractures.",
keywords = "Bone mineral density, Fragility fracture, Hemophilia, Joint arthropathy, Osteopenia, Osteoporosis",
author = "Ursa Broum-Glaberman and Kissee, {Michelle Cordoba} and Damiano, {Mary Lou} and Denise Roe and Stopeck, {Alison T}",
year = "2011",
month = "10",
language = "English (US)",
volume = "3",
pages = "27--33",
journal = "Journal of Coagulation Disorders",
issn = "2041-7969",
publisher = "San Lucas Medical",
number = "1",

}

TY - JOUR

T1 - Decreased bone mineral density in adult patients with Hemophilia

T2 - Clinical significance, prevalence and risk factors

AU - Broum-Glaberman, Ursa

AU - Kissee, Michelle Cordoba

AU - Damiano, Mary Lou

AU - Roe, Denise

AU - Stopeck, Alison T

PY - 2011/10

Y1 - 2011/10

N2 - Osteoporosis is widely recognized as a major health problem, and considerable resources are spent screening, diagnosing, and treating this disease in postmenopausal women. Adults with hemophilia have unique factors that place them at an increased risk for developing osteoporosis including periods of immobilization after bleeds, impaired joint mobility that may limit weight bearing physical activity, and infection with Hepatitis C virus (HCV) and/orhuman immunodeficiency virus (HIV). Several publications report the prevalence of osteoporosis in adults with hemophilia to be in the range of 25% and 50%. The severity of hem ophilic joint arthropathy appears to be the strongest predictor of significant bone loss in patients with hemophilia. The relative contribution of other risk factors, including HIV and HCV, is less well defined. The clinical significance of decreased bone mineral density as measured by dual energy X-ray absorptiometry (DXA) to fracture risk in men, and in particularyounger men, is also unclear. We recommend screening adult patients with hemophilia with documented fragility fractures, in those with severe joint arthropathy, and in those patients > 50 years of age with additional risk factors such as HIV/HCV infection or low BMI. Adequate vitamin D and calcium intake, weight bearing physical activity, and interventions to maintain joint mobility are recommended for all hemophilia patients. The role of pharmacologic agents, including bisphosphonates, is untested, and they should be reserved for those with documented osteoporosis and fragility fractures or additional risk factors that place them at high risk for developing fragility fractures.

AB - Osteoporosis is widely recognized as a major health problem, and considerable resources are spent screening, diagnosing, and treating this disease in postmenopausal women. Adults with hemophilia have unique factors that place them at an increased risk for developing osteoporosis including periods of immobilization after bleeds, impaired joint mobility that may limit weight bearing physical activity, and infection with Hepatitis C virus (HCV) and/orhuman immunodeficiency virus (HIV). Several publications report the prevalence of osteoporosis in adults with hemophilia to be in the range of 25% and 50%. The severity of hem ophilic joint arthropathy appears to be the strongest predictor of significant bone loss in patients with hemophilia. The relative contribution of other risk factors, including HIV and HCV, is less well defined. The clinical significance of decreased bone mineral density as measured by dual energy X-ray absorptiometry (DXA) to fracture risk in men, and in particularyounger men, is also unclear. We recommend screening adult patients with hemophilia with documented fragility fractures, in those with severe joint arthropathy, and in those patients > 50 years of age with additional risk factors such as HIV/HCV infection or low BMI. Adequate vitamin D and calcium intake, weight bearing physical activity, and interventions to maintain joint mobility are recommended for all hemophilia patients. The role of pharmacologic agents, including bisphosphonates, is untested, and they should be reserved for those with documented osteoporosis and fragility fractures or additional risk factors that place them at high risk for developing fragility fractures.

KW - Bone mineral density

KW - Fragility fracture

KW - Hemophilia

KW - Joint arthropathy

KW - Osteopenia

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=84873599871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873599871&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 27

EP - 33

JO - Journal of Coagulation Disorders

JF - Journal of Coagulation Disorders

SN - 2041-7969

IS - 1

ER -